Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.67 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.67 |
| ▸ | AHR | P35869 | 2/20 | 0.45 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.41 |
| ▸ | BLM | P54132 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | CCR1 | P32246 | 1/20 | 0.40 |
| ▸ | CCR5 | P51681 | 1/20 | 0.40 |
| ▸ | CCR8 | P51685 | 1/20 | 0.40 |
| ▸ | METAP1 | P53582 | 1/20 | 0.40 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.40 |
| ▸ | DOHH | Q9BU89 | 1/20 | 0.40 |
| ▸ | P4HTM | Q9NXG6 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29965849 | 1.00 | SMN1; SMN2 (0.67) | SMN1; SMN2L3MBTL1AHRCHRM2BLM | |
| SCHEMBL6921056 | 0.86 | SMN1; SMN2 (0.67) | SMN1; SMN2L3MBTL1AHRCHRM2BLM | |
| SCHEMBL12717303 | 0.86 | SMN1; SMN2 (0.67) | SMN1; SMN2L3MBTL1AHRCHRM2BLM | |
| SCHEMBL4388586 | 0.86 | SMN1; SMN2 (0.67) | SMN1; SMN2L3MBTL1AHRCHRM2BLM | |
| SCHEMBL27997203 | 0.84 | SMN1; SMN2 (0.64) | SMN1; SMN2L3MBTL1AHRCHRM2BLM | |
| SCHEMBL10442032 | 0.82 | SMN1; SMN2 (0.61) | SMN1; SMN2L3MBTL1AHRCHRM2BLM | |
| SCHEMBL21742008 | 0.82 | SMN1; SMN2 (0.61) | SMN1; SMN2L3MBTL1AHRCHRM2BLM | |
| SCHEMBL16230664 | 0.82 | SMN1; SMN2 (0.61) | SMN1; SMN2L3MBTL1AHRCHRM2BLM | |
| SCHEMBL17490343 | 0.81 | SMN1; SMN2 (0.55) | SMN1; SMN2L3MBTL1AHRCHRM2BLM | |
| SCHEMBL21883522 | 0.81 | L3MBTL1 (0.55) | SMN1; SMN2L3MBTL1AHRCHRM2BLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 214 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240189805-A1 | CATALYSTS AND METHODS FOR THE HYDRATION AND ABSORPTION OF CARBON DIOXIDE | AIR COMPANY HOLDINGS, INC. | 2024-06-13 | — | — | US | claimed |
| EP-4341235-A1 | METHOD AND APPARATUS FOR SELECTIVE ALCOHOL UPGRADING | Air Company Holdings, Inc. (US) | 2024-03-27 | — | — | EP | claimed |
| EP-4313373-A1 | CATALYSTS AND METHODS FOR THE HYDRATION AND ABSORPTION OF CARBON DIOXIDE | Air Company Holdings, Inc. (US) | 2024-02-07 | — | — | EP | claimed |
| WO-2022245944-A1 | METHOD AND APPARATUS FOR SELECTIVE ALCOHOL UPGRADING | AIR COMPANY HOLDINGS, INC. (US) | 2022-11-24 | — | — | WO | claimed |
| WO-2022204233-A1 | CATALYSTS AND METHODS FOR THE HYDRATION AND ABSORPTION OF CARBON DIOXIDE | AIR COMPANY HOLDINGS, INC. (US) | 2022-09-29 | — | — | WO | claimed |
| CN-109153665-A | Novel 2-substituted indazoles, method for the production thereof, pharmaceutical preparations containing the same and use thereof for producing medicaments | 拜耳医药股份有限公司 | 2019-01-04 | — | — | CN | claimed |
| US-9790605-B2 | Iridium complexes for electrocatalysis | YALE UNIVERSITY (US) | 2017-10-17 | — | — | US | claimed |
| CN-106795139-A | Aminopyridine base epoxide pyrazole compound | 伊莱利利公司 | 2017-05-31 | — | — | CN | claimed |
| US-20150021194-A1 | IRIDIUM COMPLEXES FOR ELECTROCATALYSIS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2015-01-22 | — | — | US | claimed |
| US-12448383-B2 | Compounds and methods for treatment of viral infections | GILEAD SCIENCES, INC. (US) | 2025-10-21 | — | — | US | disclosed |
| US-20250304577-A1 | TYK2 INHIBITORS | BIOGEN MA INC. | 2025-10-02 | — | — | US | disclosed |
| US-20250197410-A1 | COMPOUNDS AND METHODS FOR TREATMENT OF VIRAL INFECTIONS | GILEAD SCIENCES, INC. | 2025-06-19 | — | — | US | disclosed |
| US-20250178992-A1 | METHOD AND APPARATUS FOR SELECTIVE ALCOHOL UPGRADING | AIR COMPANY HOLDINGS, INC. | 2025-06-05 | — | — | US | disclosed |
| US-12252462-B2 | Method and apparatus for selective alcohol upgrading | AIR COMPANY HOLDINGS, INC. (US) | 2025-03-18 | — | — | US | disclosed |
| EP-1036081-A1 | HETEROCYCLYL LIGAND CONTAINING RUTHENIUM AND OSMIUM CATALYSTS | Ciba SC Holding AG (CH) | 2000-09-20 | — | — | EP | disclosed |
| US-5969166-A | RUTHENIUM OR MOLYBDENUM CATALYSTS FOR EPOXIDATION OF ALKENES WITH OXYGEN | HOECHST AKTIENGESELLSCHAFT (DE) | 1999-10-19 | — | — | US | disclosed |
| WO-1999029701-A1 | HETEROCYCLYL LIGAND CONTAINING RUTHENIUM AND OSMIUM CATALYSTS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 1999-06-17 | — | — | WO | disclosed |
| US-5256785-A | Smoking compositions containing an oxalate flavorant-release additive | PHILIP MORRIS INCORPORATED (US) | 1993-10-26 | — | — | US | disclosed |
| US-5172706-A | Smoking compositions containing an oxalate flavorant-release additive | PHILIP MORRIS INCORPORATED (US) | 1992-12-22 | — | — | US | disclosed |
| US-4546198-A | Asymmetric synthesis of esters and acids | SHELL OIL COMPANY (US) | 1985-10-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250178992-A1 | METHOD AND APPARATUS FOR SELECTIVE ALCOHOL UPGRADING | ADH1C, ADH1A, ADH5 | SMN1; SMN2 2967/4885L3MBTL1 3769/4885AHR 136/4885 |
| US-12252462-B2 | Method and apparatus for selective alcohol upgrading | ADH1C, ADH1A, ADH5 | SMN1; SMN2 2967/4885L3MBTL1 3769/4885AHR 136/4885 |
| US-20250304577-A1 | TYK2 INHIBITORS | TYK2, JAK2, JAK1 | SMN1; SMN2 1067/4885L3MBTL1 2886/4885AHR 2943/4885 |
| US-20150021194-A1 | IRIDIUM COMPLEXES FOR ELECTROCATALYSIS | PPOX, NOXO1, NOX3 | SMN1; SMN2 2055/4885L3MBTL1 3177/4885AHR 2388/4885 |
| US-12448383-B2 | Compounds and methods for treatment of viral infections | HAVCR2, EIF2AK2, OAT | SMN1; SMN2 1064/4885L3MBTL1 2363/4885AHR 3343/4885 |
| US-20250197410-A1 | COMPOUNDS AND METHODS FOR TREATMENT OF VIRAL INFECTIONS | HAVCR2, EIF2AK2, OAT | SMN1; SMN2 1064/4885L3MBTL1 2363/4885AHR 3343/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.